Lenacapavir Sodium
규격
2283356-12-5CAS 번호
875-171-5EC 번호
sodium [4-chloro-7-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[2-[(2S,4R)-5,5-difluoro-9-(trifluoromethyl)-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]ethyl]-6-(3-methyl-3-methylsulfonylbut-1-ynyl)-3-pyridinyl]-1-(2,2,2-trifluoroethyl)indazol-IUPAC 명칭
C39H31ClF10N7NaO5S2화학식
990.3 g/mol분자량
Lenacapavir sodium; GS-HIV Sodium; 2283356-12-5; BDT58WJ9WE; UNII-BDT58WJ9WE; GS-6207-02; Sunlenca; 1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOLE-1-ACETAMIDE, N-((1S)-1-(3-(4-CHLORO-3-((METHYLSULFONYL)AMINO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-METHYL-3-(METHYLSULFONYL)-1-BUTYN-1-YL)-2-PYRIDINYL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-5,5-DIFLUORO-3B,4,4A,5-TETRAHYDRO-3-(TRIFLUOROMETHYL)-, SODIUM SALT (1:1), (3BS,4AR)-; N-((1S)-1-(3-(4-CHLORO-3-(METHANESULFONAMIDO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-(METHANESULFONYL)-3-METHYLBUT-1-YN-1-YL)PYRIDIN-2-YL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-2-((3BS,4AR)-5,5-DIFLUORO-3-(TRIFLUOROMETHYL)-3B,4,4A,5-TETRAHYDRO1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOL-1-YL)ACETAMIDE, SODIUM SALT (1:1); RefChem:58517; GS-HIV Na; Lenacapavir sodium [USAN]; Yeztugo; Sunlenca (TN); Lenacapavir (sodium); Lenacapavir sodium [WHO-DD]; orb2814823; CHEMBL4802249; Lenacapavir sodium (JAN/USAN); SCHEMBL30612482; SCHEMBL30685531; EX-A5518A; HY-111964A; D12162; T202890; sodium [4-chloro-7-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[2-[(2S,4R)-5,5-difluoro-9-(trifluoromethyl)-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]ethyl]-6-(3-methyl-3-methylsulfonylbut-1-ynyl)-3-pyridinyl]-1-(2,2,2-trifluoroethyl)indazol-3-yl]-methylsulfonylazanide동의어
Lenacapavir Sodium 함유 제품
선렌카정(레나카파비르나트륨)선렌카주(레나카파비르나트륨)SUNLENCA 464 MG SOLUCION INYECTABLESUNLENCA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULASUNLENCA 464 mg, solution injectableSUNLENCA 300 mg, comprimé pelliculéLenacapavir Sodium - F.I.S. Fabbrica Italiana SinteticiLenacapavir Sodium - Hetero DrugsLenacapavir SodiumLenacapavir SodiumNantong Noatic Bio-Pharm technology Co., Ltd. sell "Lenacapavir"
